InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Schnettler Thomas P, 董事. Director active across 2 companies, notably Paragon 28, Inc.. In total, 7 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €996k. History available since 14 October 2021. The latest transaction was filed on 17 May 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Schnettler Thomas P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
45,035 股Common StockSEC:0000950170-25-056368:0
15,906 股0Common StockSEC:0001610717-24-000249:0
6,900 股@ US$18.5437100.0% 占其流量Common StockSEC:0001610717-23-000170:0
8,361 股0Common StockSEC:0001610717-23-000054:0
71,050 股@ US$13.03100.0% 占其流量Common StockSEC:0001104659-22-128617:0
8,918 股0Common StockSEC:0001567619-22-011422:0
18,750 股0Common StockSEC:0001567619-21-021593:0
7 条申报中的 7 条
About Schnettler Thomas P
Thomas P Schnettler is a Director of Paragon 28, Inc. and Akoya Biosciences, Inc. He has 7 filings in total. Across the 7 recent filings tracked, from 2021-12-03 to 2025-04-21, the reported activity shows EUR 996209 of sales, and the most frequent transaction nature is listed as Attribution.
